Shimon Orit, Green Hefziba, Eliakim-Raz Noa, Rozen-Zvi Benaya, Ben-Zvi Haim, Zohar Iris, Bishara Jihad, Yahav Dafna
Clin Nephrol. 2018 Aug;90(2):117-124. doi: 10.5414/CN109172.
Bloodstream infections (BSIs) are an important cause of hospitalizations and mortality among hemodialysis (HD) patients. Epidemiology of these infections is changing, with increasing rates of Gram-negative pathogens, including resistant ones. Few studies have focused on the characteristics and outcomes of these infections.
We aimed to document the causative pathogens of BSIs in HD patients and their clinical outcomes during 2008 - 2015, and to compare risk factors, clinical features, appropriateness of therapy, and outcomes between patients with Gram-negative vs. Gram-positive BSIs.
A single-center retrospective cohort study. Charts of 120 HD patients hospitalized with first BSI were reviewed.
A total of 120 patients were included, 61 episodes of Gram-negative (51.8%) and 59 episodes of Gram-positive bacteria (49.2%). Source of infection was significantly more likely to be urinary or abdominal among patients with Gram-negative infection. Otherwise, no statistically significant differences were documented between groups in terms of baseline characteristics, presentation of infection and outcomes. Most Gram-negative BSIs were caused by enterobacteriaceae, followed by Pseudomonas spp. Previous clinical or surveillance cultures added little to accurate prediction of the causative organism.
CONCLUSION: In a cohort of HD patients with BSI, no significant differences were found between Gram-negative and Gram-positive BSIs, besides source of infection. A urinary or abdominal source strongly suggests a Gram-negative pathogen. Otherwise, patient's characteristics, clinical presentation, and previous cultures, all cannot accurately predict the causative pathogen of BSI, and broad-spectrum antibiotics should be used empirically. .
血流感染(BSIs)是血液透析(HD)患者住院和死亡的重要原因。这些感染的流行病学正在发生变化,革兰氏阴性病原体(包括耐药菌)的感染率不断上升。很少有研究关注这些感染的特征和结局。
我们旨在记录2008年至2015年期间HD患者血流感染的致病病原体及其临床结局,并比较革兰氏阴性与革兰氏阳性血流感染患者之间的危险因素、临床特征、治疗的合理性及结局。
一项单中心回顾性队列研究。回顾了120例因首次血流感染住院的HD患者的病历。
共纳入120例患者,革兰氏阴性菌感染61例(51.8%),革兰氏阳性菌感染59例(49.2%)。革兰氏阴性菌感染患者的感染源更可能是泌尿系统或腹部。除此之外,两组在基线特征、感染表现和结局方面未发现统计学上的显著差异。大多数革兰氏阴性血流感染由肠杆菌科引起,其次是假单胞菌属。既往的临床或监测培养对准确预测致病微生物的作用不大。
在一组血流感染的HD患者中,除感染源外,革兰氏阴性和革兰氏阳性血流感染之间未发现显著差异。泌尿系统或腹部感染源强烈提示革兰氏阴性病原体。否则,患者的特征、临床表现和既往培养结果均不能准确预测血流感染的致病病原体,应经验性使用广谱抗生素。